Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belpointe Asset Management LLC increased its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 54.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 709 shares of the biotechnology company’s stock after buying an additional 251 shares during […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Repligen Co. (NASDAQ:RGEN – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,780,000 shares, a growth of 21.4% from the April 15th total of 2,290,000 shares. Based on an average trading volume of 519,600 shares, the days-to-cover […]
Equities analysts expect Repligen Co. (NASDAQ:RGEN – Get Rating) to announce earnings of $0.73 per share for the current quarter, Zacks reports. Six analysts have made estimates for Repligen’s earnings, with the highest EPS estimate coming in at $0.80 and the lowest estimate coming in at $0.66. Repligen reported earnings per share of $0.79 in […]